Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (281-290 of 308) with videos related to

Pageof 31
Sort By:
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Journal of Neuro-Oncology|May 2, 2023
Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research NetworkMichael C Dewan, Albert M Isaacs, Michael J Cools, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Arxiv|December 18, 2023
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor NetworkAriana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, et al.
Journal of Neuro-Oncology|May 12, 2026
Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi studyDavid S Hersh, Anthony L Asher, Mohamad Bydon, et al.
Nature Cell Biology|February 27, 2023
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasisHan Zou, Bradley Poore, Emily E Brown, et al.
The Journal of Pediatrics|January 18, 2026
Necrotizing Enterocolitis and Shunt Survival in Premature Infants with Posthemorrhagic Hydrocephalus: A Hydrocephalus Clinical Research Network StudyVijay M Ravindra, John R W Kestle, Hailey Jensen, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Pageof 31

Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Science Translational Medicine|March 19, 2025
The T cell receptor landscape of childhood brain tumorsItay Raphael, Zujian Xiong, Chaim T Sneiderman, et al.
Journal of Neuro-Oncology|May 2, 2023
Treatment of hydrocephalus following posterior fossa tumor resection: a multicenter collaboration from the Hydrocephalus Clinical Research NetworkMichael C Dewan, Albert M Isaacs, Michael J Cools, et al.
The Lancet. Oncology|June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trialJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Arxiv|December 18, 2023
A multi-institutional pediatric dataset of clinical radiology MRIs by the Children's Brain Tumor NetworkAriana M Familiar, Anahita Fathi Kazerooni, Hannah Anderson, et al.
Journal of Neuro-Oncology|May 12, 2026
Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi studyDavid S Hersh, Anthony L Asher, Mohamad Bydon, et al.
Nature Cell Biology|February 27, 2023
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasisHan Zou, Bradley Poore, Emily E Brown, et al.
The Journal of Pediatrics|January 18, 2026
Necrotizing Enterocolitis and Shunt Survival in Premature Infants with Posthemorrhagic Hydrocephalus: A Hydrocephalus Clinical Research Network StudyVijay M Ravindra, John R W Kestle, Hailey Jensen, et al.
Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Nature Cancer|June 23, 2022
Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.
Pageof 31